Split-hand/split-foot malformation (SHFM) is a severe form of congenital limb deformity characterized by the absence of 1 or more digits and/or variable degree of median clefts of hands and feet. The present study describes an investigation of a consanguineous family of Pakistani origin segregating SHFM in an autosomal recessive manner. Human genome scan using SNP markers followed by whole exome sequencing revealed a frameshift deletion (c.409delA, p. Ser137Alafs*19) in the EPS15L1 gene located on chromosome 19p13.11. This is the first biallelic variant identified in the EPS15L1 gene underlying SHFM. Our findings report the first direct involvement of EPS15L1 gene in the development of human limbs.
| INTRODUCTION
Split-hand/foot malformation (SHFM) is a classical form of ectrodactyly, also known as lobster claw deformity. It is a developmental limb disorder characterized by the absence of 1 or more digits of hand/ foot with a variable degree of median clefts. It is often accompanied by other limb anomalies including syndactyly/polydactyly, hypoplasia or aplasia of the phalanges (the digits), metacarpals, and metatarsals.
The clinical picture of SHFM varies in severity from patient to patient as well between the limbs in the same individual. 1, 2 To date, 10 various types of SHFM have been mapped on different human chromosomes. This included SHFM1 on chromosome 7q21 (MIM 183600), 3 
| MATERIALS AND METHODS

| Human subjects
Approval of the study was provided by Institutional Review Board (IRB) of Quaid-i-Azam University, Islamabad, Pakistan. Informed consent was obtained from all those who participated in the study.
| Isolation of genomic DNA
Peripheral blood samples were obtained from 2 affected (IV-2, IV-5) and 3 unaffected individuals (III-1, IV-3, IV-4) ( Figure 1A ).
Genomic DNA was extracted and quantified using standard procedures.
| Karyotype analysis
Karyotype analysis was performed on peripheral blood lymphocytes collected from the proband (IV-2) using the G-banding technique. 10 
| Human genome scan
DNA of both affected and unaffected individuals were subjected to SNP analysis, using Affymetrix GeneChip Human Mapping 250 K Nsp array. 15 
| Whole exome sequencing (WES)
DNA of affected individual (IV-2) was subjected to WES using Agilent SureSelect Target Enrichment Kit and libraries were sequenced using Illumina HiSeq 2500 (Illumina, San Diego, CA, US). 16 After WES, only those biallelic variants were filtered that were present within the homozygous regions obtained after SNP array and further validated using Sanger sequencing.
3 | RESULTS Cytogenetic analysis revealed an apparently normal male (IV-2) karyotype of 46, XY after G-banding (not shown). Therefore, no gross structural/numerical chromosomal abnormality was detected.
| Clinical features
| Genotyping and WES
In the present family, analysis of SNP array data revealed mapping of several small homozygous regions on different chromosomes includ- information about the filtration steps and the screening of candidate variant has been presented in Table S3 .
| DISCUSSION
The present report revealed the first direct evidence of the involve- phenotypes. [17] [18] [19] This included a combination of features like SHFM, tetralogy of Fallot (heart defect), deep set eyes, strabismus, developmental delay, microcephaly, pre-axial polydactyly, and cutaneous syndactyly resulted from a deletion of 1 Mb on chromosome 19p13.11. 17 Similar features were reported in a fetus with a 24 Mb deletion on chromosome 19p13.3-p12. 19 Bens et al. 18 described 2 patients manifesting features such as deep set eyes, strabismus, and developmental delay, resulted from deletion of 1.07 to 1.12 Mb on chromosome 19p13.11. However, conditions of SHFM, pre-axial polydactyly, syndactyly and heart defects were not observed in the latter 2 patients. As reported by the authors, 2 genes EPS15L1 and CALR3 were retained in these patients. Data presented in these 3 reports [17] [18] [19] and identification of the frameshift mutation (p. Ser137Alafs*19) identified in the present study is located in the highly conserved EH2 domain ( Figure 1K ,L). EPS15L1 mostly functions as a substrate for tyrosine kinase activity of the epidermal growth factor receptor (EGFR), which is generally allied with limb morphogenesis. 21 The EGFR signaling pathway is mostly involved in survival, growth, differentiation, proliferation and mostly associated with limb development via the apical ectodermal ridge (AER). [22] [23] [24] Both environmental factors and genetic defects might cause SHFM phenotypes by interfering with the AER. 25 Any pathogenic mutation in the EPS15L1 gene might change EPS15L1 protein dosage, and thus reducing the substrate concentration. The reduced substrate might lead to a decreased tyrosine kinase activity of EGFR.
Our report supports the notion that pathogenic biallelic variants in the gene EPS15L1 might be the causes of SHFM, nevertheless 
